搜尋
Q C Technologies Ord Shs
QCLS添加自選
0.865USD
-0.028-3.13%
交易中 09/23, 14:38（美東）
6.79M總市值
0.03本益比TTM
關於 公司
Q C Technologies Ord Shs 簡介
公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -
Q C Technologies Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Ms. Chelsea Voss
Ms. Chelsea Voss
Director
Director
239.90K
--
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Chelsea Voss
Ms. Chelsea Voss
Director
Director
239.90K
--
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
常見問題
Q C Technologies Ord Shs的前五大股東是誰？
Q C Technologies Ord Shs的前五大股東如下：Ms. Chelsea Voss
哪個業務部門對Q C Technologies Ord Shs的收入貢獻最大？
在2026Q4，Particle ImmunoFiltration Assay (“PIFA”)業務部門對Q C Technologies Ord Shs的收入貢獻最大，創收1.33M，占總收入的84.19% 。